Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$0.10 and traded as low as C$0.09. Resverlogix shares last traded at C$0.10, with a volume of 47,210 shares.
Resverlogix Stock Performance
The firm has a market cap of C$30.04 million, a PE ratio of -3.17 and a beta of 0.72. The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11. The firm’s 50 day simple moving average is C$0.10 and its 200 day simple moving average is C$0.10.
Resverlogix (TSE:RVX – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The biotechnology company reported C$0.01 EPS for the quarter. On average, research analysts forecast that Resverlogix Corp. will post -0.22 EPS for the current fiscal year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
